TGFB1 and Huntington disease: There were no statistically significant differences in plasma levels of TGF-β1 between HD patients and the control group, or between individual stages of the disease, which is not surprising as similar results were also obtained in other laboratories [8,9,14,15,16,20,21,22,23].